Thomas W. Bond, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1331 Minnich Rd, New Haven, IN 46774 Phone: 260-425-5000 Fax: 260-425-5048 |
Rebecca M. Baker-palmer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1302 Minnich Rd, New Haven, IN 46774 Phone: 260-458-3200 Fax: 260-458-3205 |
Christi Ann Wallace, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1302 Minnich Rd, New Haven, IN 46774 Phone: 260-458-3200 Fax: 260-458-3205 |
Guy T Joassin, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16617 Darling Rd, New Haven, IN 46774 Phone: 260-657-1335 |
Michael S. Rumple, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1331 Minnich Rd, New Haven, IN 46774 Phone: 260-425-5000 Fax: 260-425-5048 |
Thomas D. Smith Iii, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1331 Minnich Rd, New Haven, IN 46774 Phone: 260-373-9600 Fax: 260-373-9602 |
Lawrence F. Wuest, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1331 Minnich Rd, New Haven, IN 46774 Phone: 260-425-5000 Fax: 260-425-5048 |
News Archive
In a Journal of Bone and Mineral Research study that followed 186 children with Acute Lymphoblastic Leukemia (ALL) for 6 years after initiation of chemotherapy, approximately 1 in 5 children experienced a non-vertebral fracture and 1 in 3 had a new vertebral fracture.
"Around the world, frontline health workers are often the first link to lifesaving care and supplies, and in some cases they are the only link for families and communities in rural and impoverished areas," Oying Rimon, a senior program officer in family health at the foundation, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Recombinant Data Corp., a Massachusetts-based healthcare data warehousing and clinical intelligence solutions provider, today announced its continued contributions to innovative IT tools for clinical research, through the company's key role in the U.S. Department of Veterans Affairs' Million Veteran Program (MVP).
Taking advantage of the chemical properties of botulism toxins, two teams of researchers have fashioned non-toxic versions of these compounds that can deliver therapeutic antibodies to treat botulism, a potentially fatal disease with few approved treatments.
A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal of the National Cancer Institute.
› Verified 8 days ago